VICTORIA, BC, April 14 /CNW/ - After careful review of clinical and
safety data by their medical panel, The Eczema Society of Canada has
accepted DermaSilk® for use by persons with eczema and or sensitive
skin conditions. The acceptance is not a direct endorsement, rather,
the goal of the Seal of Acceptance program is patient empowerment,
education and support. The Eczema Society's goal is to work toward
bettering the health and quality of life for eczema sufferers.
"We are thrilled to see DermaSilk® recognized by an independent
scientific review," says Dan Sharp, CEO of Western Allergy Services
regarding the Society's Seal of Acceptance. "DermaSilk® offers an
innovative approach to the treatment of eczema and we are pleased to
see it acknowledged as a viable part of the treatment regime by
Canada's skin care experts."
DermaSilk® is a breakthrough in the treatment of eczema and other forms
of atopic dermatitis and shows that what you wear can alter the effect
of your eczema treatment.
Scientists involved in treating allergic skin conditions such as atopic
dermatitis and eczema have turned their attention to the type of
clothing worn by patients and have come up with a modernized fabric
which has been shown in clinical trials to offer significant advantages
over commonly used clothing. This innovative product range is now
available in Canada through Western Allergy Services, a Canadian
company with over 35 years of expertise in the treatment of allergic
DermaSilk® Therapeutic Clothing offers a patented approach to managing
skin conditions for all age groups and for any part of the body.
Comprised of a range of light-weight therapeutic clothing made of
hypoallergenic medical grade 100% silk fibroin, DermaSilk® is also
embedded with a special permanent and chemical free antimicrobial
protection shield (AEM 5772/5). This antimicrobial fabric is the same
one that has been used in operating rooms over the past 30 years.
By combining the properties of knitted pure silk fibroin (softness, high
breathing and heat-regulating capacity) and of the antimicrobial
shield, DermaSilk® helps to restore the barrier function of the skin,
altered by flares, irritations and infections associated with atopic
dermatitis. Unlike bioactive fabrics containing silver, the bonded
antimicrobial protects against a wide range of microbes without
releasing chemicals onto the skin.
DermaSilk® provides the nearest thing to a second skin for the
management of allergic skin conditions.
Atopic dermatitis takes a toll on Canadians
It is estimated that 15-20 percent of Canadians1 suffer from eczema and/or atopic dermatitis. Eczema and/or any other
form of atopic dermatitis is a multi-faceted condition, varying in
duration, extent and severity amongst patients. Consequently, the
delivery of patient care has nearly as many variations as there are
eczema patients in Canada. The Eczema Society of Canada recommends the
'Triangle of Control'. This triad combination involves an emphasis on
hydration, medication management, and education. DermaSilk® offers an
additional aid in eczema care.
Studies indicate that atopic dermatitis imposes a significant financial
burden as well, with total costs estimated at Cdn $1.4 billion
annually. A recent Canadian review2 cited that more than half of patients with atopic dermatitis experience
sleep disturbances owing to their condition and 71% have reported
concerns about topical corticosteroid use. The study concluded that
the total cost to society is large and that most of the cost is borne
by patients and their employers. A drug free solution such as
DermaSilk® is a breakthrough that is long overdue.
The worst and most difficult elements to control are the itching and
scratching which leads to weeping and bleeding skin resulting in
discomfort, sleepless nights and possible infections. Until now there
have been few dressing options that can alleviate this condition. Cost
benefit analysis of DermaSilk® has been shown to greatly reduce the
medication costs to patients and the health care system from 75% with
mild to moderate sufferers to a whopping 596% for severe patients. In
recognition of this cost savings, health authorities in Europe and the
UK now include DermaSilk® in the list of prescribed items covered by
National Health Services.
In published clinical trials3,4,5, the patented DermaSilk® system has been proven to rapidly and
significantly outperform cotton clothing in contributing to the
reduction of irritation, itching and scratching associated with
compromising skin conditions such atopic dermatitis, while enhancing
the activity of conventional medication4. This ultimately enables patients to increase comfort, heal faster,
sleep better and reduce their use of topical antibiotics and steroids.
Dr. Rupert Mason, medical advisor to DermSilk® in the UK, said: "Eczema
can be one of the most distressing conditions that children can suffer
and it torments them in many ways. The introduction of the DermaSilk®
clothing range has many benefits not only for its therapeutic value but
also in its design and construction, as the range looks very normal,
reducing the self-conscious element children feel in front of their
DermaSilk® Therapeutic Clothing is available for all age groups and for
any part of the body. It is used for eczema and a growing list of other
skin disorders, including acne, burn care, diabetic ulcers, lichen
sclerosis, thrush, and Epidermolysis bullosa. The DermaSilk® range
includes undershirts, pants, baby suits, gloves, underwear and
leggings. DermaSilk® can be ordered directly from Western Allergy
Services via their web site, www.DermaSilk.ca or from select pharmacies and medical professionals.
References: 1. Eczema society of Canada: http://eczemahelp.ca/what.html quoted March 15, 2011. 2. Barbeau M, Lalonde H: Burden of Atopic dermatitis in Canada. International Journal of Dermatology 2006, 45, 31-36. 3.Ricci G, Patrizi A, Bendandi B, Menna G, Varotti, E, Masi M. Clinical
effectiveness of a silk fabric in the treatment of atopic dermatitis. Br J Dermatol 2004: 150: 127-31. 4.Senti G, Steinmann LS, Fischer B, Kurmann R, Storni T, Johansen P,
Schmid-Grendelmeier P, Wuthrich B, Kundig TM: Antimicrobial silk
clothing in the treatment of atopic dermatitis proves comparable to
topical corticosteroid treatment. Dermatology 2006; 213:228-233. 5.Stinco G, Piccirillo F, Valent F: A Randomized Double-Blind Study to
Investigate the Clinical Efficacy of Adding a Non-Migrating
Antimicrobial to a Special Silk Fabric in the Treatment of Atopic
Dermatitis. Dermatology 2008;217:191-195.
/NOTE TO PHOTO EDITORS: The photo accompanying this release is also
available at http://photos.newswire.ca. Images are free to accredited members of the media/
SOURCE Western Allergy Services
For further information:
Western Allergy Services
Ms. Genevieve Grant
For more information about the Eczema Society of Canada, contact:
Amanda Cresswell-Melville, Executive Director